G1 Therapeutics Announces Top Line Results from Pivotal
- PRESERVE 1 Achieved its Co-Primary Endpoints Showing Statistically Significant Reductions in Occurrence of Severe
Globe Newswire13-02-2023, 18:03
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are 10-09-2024, 19:00